CUV — Clinuvel Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapContrarian

Annual balance sheet for Clinuvel Pharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th	2026 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	122	157	184	224	252
Net Total Accounts Receivable
Net Total Receivables	16.2	22.2	26.2	27.5	23.5
Total Inventory
Prepaid Expenses
Total Current Assets	141	190	222	263	285
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.7	2.85	7.72	7.13	9.25
Net Goodwill
Other Long Term Assets
Total Assets	144	194	231	272	295
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	13.7	25.5	25.2	27.2	19.2
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	18.4	29.1	28.1	30.9	22.2
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	126	165	203	241	273
Total Liabilities & Shareholders' Equity	144	194	231	272	295
Total Common Shares Outstanding